Acrivon Therapeutics, Inc. Common Stock (ACRV) — Analyst estimates
Consensus analyst estimates for Acrivon Therapeutics, Inc. Common Stock — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 583K | -0.51 | 1 |
| 2027 | 0 | -0.52 | 1 |
| 2028 | 21.38M | -1.9 | 5 |
| 2029 | 61.93M | -1.58 | 1 |
| 2030 | 130.67M | -0.89 | 1 |
Consensus analyst estimates by fiscal year.